Literature DB >> 4605026

Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line.

B W Papermaster, O A Holtermann, D Rosner, E Klein, T Dao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4605026

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


× No keyword cloud information.
  5 in total

1.  Lymphotoxin production by regional lymph node lymphocytes in patients with uterine cervical cancer.

Authors:  K Matsunaga; H Mashiba; A Kurano; S Jimi
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

Review 2.  Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Authors:  I J Fidler; G Poste
Journal:  Springer Semin Immunopathol       Date:  1982

3.  The systemic activation of macrophages by liposomes containing immunomodulators.

Authors:  R Nayar; I J Fidler
Journal:  Springer Semin Immunopathol       Date:  1985

Review 4.  Macrophages and cancer.

Authors:  P W Whitworth; C C Pak; J Esgro; E S Kleinerman; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

5.  Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.

Authors:  E S Kleinerman; A J Schroit; W E Fogler; I J Fidler
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.